Literature DB >> 2052197

Staircase bioassay: the up-and-down method.

W J Dixon1.   

Abstract

Experiments are conducted to estimate the threshold for an all-or-none response. Threshold is defined to be a point above which 50% of the subjects will respond and below which 50% of the subjects will not respond. Examples are death, death in a fixed time period, shock, fibrillation, emesis. Staircase designs, in particular up-and-down trials, produce median (ED50) estimates of given standard error with as few as one-fifth the number of subjects as the traditional designs with preset numbers of tests at each of several levels of stimulus. We discuss these estimates and their efficiency as well as procedures to estimate standard deviation and its use in designing up-and-down trails. The advantages in using several short series in factorial experiments are presented. Suggestions are given for minimizing the complications of sequential designs. Case studies indicate the efficiency of the design for various applications.

Entities:  

Mesh:

Year:  1991        PMID: 2052197     DOI: 10.1016/s0149-7634(05)80090-9

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  173 in total

1.  The effect of opioid and acepromazine premedication on the anesthetic induction dose of propofol in cats.

Authors:  T L Hall; T Duke; H G Townsend; N A Caulkett; S L Cantwell
Journal:  Can Vet J       Date:  1999-12       Impact factor: 1.008

2.  A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants.

Authors:  Young-Eun Jang; Yong-Chul Kim; Hyun-Kyu Yoon; Young-Tae Jeon; Jung-Won Hwang; Eugene Kim; Hee-Pyoung Park
Journal:  J Anesth       Date:  2014-11-14       Impact factor: 2.078

3.  Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury.

Authors:  Supinder S Bedi; Qing Yang; Robyn J Crook; Junhui Du; Zizhen Wu; Harvey M Fishman; Raymond J Grill; Susan M Carlton; Edgar T Walters
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

4.  Activation of enkephalinergic (Enk) interneurons in the central amygdala (CeA) buffers the behavioral effects of persistent pain.

Authors:  Tanvi Paretkar; Eugene Dimitrov
Journal:  Neurobiol Dis       Date:  2018-12-17       Impact factor: 5.996

5.  Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy.

Authors:  Mae-Hwa Kang; Ho-Jin Lee; Young-Jin Lim; Young-Tae Jeon; Jung-Won Hwang; Hee-Pyoung Park
Journal:  J Anesth       Date:  2014-09-28       Impact factor: 2.078

6.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

7.  Effective dose of nefopam in 80% of patients (ED80): a study using the continual reassessment method.

Authors:  Hélène Beloeil; Mathilde Eurin; Aude Thévenin; Dan Benhamou; Jean-Xavier Mazoit
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

8.  Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients.

Authors:  Eui-Kyoung Goo; Ah-Young Oh; Suk-Ju Cho; Kwang-Suk Seo; Young-Tae Jeon
Journal:  Drugs Aging       Date:  2012-11       Impact factor: 3.923

9.  Desflurane requirements for laryngeal mask airway insertion during inhalation induction.

Authors:  Hwa-Yong Shin; Jung-Ae Lim; Seong-Hyop Kim; Seung-Woo Baek; Duk-Kyung Kim
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

10.  Low dose of fentanyl reduces predicted effect-site concentration of propofol for flexible laryngeal mask airway insertion.

Authors:  Junko Yumura; Yoshihiko Koukita; Ken-ichi Fukuda; Yuzuru Kaneko; Tatsuya Ichinohe
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.